These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses. Ringel O; Vieillard V; Debré P; Eichler J; Büning H; Dietrich U Viruses; 2018 Apr; 10(4):. PubMed ID: 29662026 [TBL] [Abstract][Full Text] [Related]
54. Is developing an HIV-1 vaccine possible? Haynes BF; Liao HX; Tomaras GD Curr Opin HIV AIDS; 2010 Sep; 5(5):362-7. PubMed ID: 20978375 [TBL] [Abstract][Full Text] [Related]
55. A tale of four studies: HIV vaccine immunogenicity and efficacy in clinical trials. Zolla-Pazner S; Michael NL; Kim JH Lancet HIV; 2021 Jul; 8(7):e449-e452. PubMed ID: 34029515 [TBL] [Abstract][Full Text] [Related]
56. Complex immune correlates of protection in HIV-1 vaccine efficacy trials. Tomaras GD; Plotkin SA Immunol Rev; 2017 Jan; 275(1):245-261. PubMed ID: 28133811 [TBL] [Abstract][Full Text] [Related]
57. Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial. Rerks-Ngarm S; Pitisuttithum P; Excler JL; Nitayaphan S; Kaewkungwal J; Premsri N; Kunasol P; Karasavvas N; Schuetz A; Ngauy V; Sinangil F; Dawson P; deCamp AC; Phogat S; Garunathan S; Tartaglia J; DiazGranados C; Ratto-Kim S; Pegu P; Eller M; Karnasuta C; Montefiori DC; Sawant S; Vandergrift N; Wills S; Tomaras GD; Robb ML; Michael NL; Kim JH; Vasan S; O'Connell RJ; J Infect Dis; 2017 Apr; 215(8):1255-1263. PubMed ID: 28329190 [TBL] [Abstract][Full Text] [Related]
58. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. Belshe RB; Graham BS; Keefer MC; Gorse GJ; Wright P; Dolin R; Matthews T; Weinhold K; Bolognesi DP; Sposto R JAMA; 1994 Aug; 272(6):475-80. PubMed ID: 7913731 [TBL] [Abstract][Full Text] [Related]
59. Support for the RV144 HIV vaccine trial. Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455 [No Abstract] [Full Text] [Related]